Literature DB >> 29205401

How many proteins can be identified in a 2DE gel spot within an analysis of a complex human cancer tissue proteome?

Xianquan Zhan1,2,3,4, Haiyan Yang1,2,3, Fang Peng1,2,3, Jianglin Li5, Yun Mu1,2,3, Ying Long1,2,3, Tingting Cheng1,2,3, Yuda Huang1,2,3, Zhao Li6, Miaolong Lu1,2,3, Na Li1,2,3, Maoyu Li1,2,3, Jianping Liu7, Peter R Jungblut8.   

Abstract

Two-dimensional gel electrophoresis (2DE) in proteomics is traditionally assumed to contain only one or two proteins in each 2DE spot. However, 2DE resolution is being complemented by the rapid development of high sensitivity mass spectrometers. Here we compared MALDI-MS, LC-Q-TOF MS and LC-Orbitrap Velos MS for the identification of proteins within one spot. With LC-Orbitrap Velos MS each Coomassie Blue-stained 2DE spot contained an average of at least 42 and 63 proteins/spot in an analysis of a human glioblastoma proteome and a human pituitary adenoma proteome, respectively, if a single gel spot was analyzed. If a pool of three matched gel spots was analyzed this number further increased up to an average of 230 and 118 proteins/spot for glioblastoma and pituitary adenoma proteome, respectively. Multiple proteins per spot confirm the necessity of isotopic labeling in large-scale quantification of different protein species in a proteome. Furthermore, a protein abundance analysis revealed that most of the identified proteins in each analyzed 2DE spot were low-abundance proteins. Many proteins were present in several of the analyzed spots showing the ability of 2DE-MS to separate at the protein species level. Therefore, 2DE coupled with high-sensitivity LC-MS has a clearly higher sensitivity as expected until now to detect, identify and quantify low abundance proteins in a complex human proteome with an estimated resolution of about 500 000 protein species. This clearly exceeds the resolution power of bottom-up LC-MS investigations.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Protein species; Proteome; Resolution; Tandem mass spectrometry; Two-dimensional gel electrophoresis

Mesh:

Substances:

Year:  2018        PMID: 29205401     DOI: 10.1002/elps.201700330

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  21 in total

1.  Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.

Authors:  Xianquan Zhan; Yuda Huang; Ying Long
Journal:  J Vis Exp       Date:  2018-04-02       Impact factor: 1.355

2.  Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas.

Authors:  Dan Liu; Jiajia Li; Na Li; Miaolong Lu; Siqi Wen; Xianquan Zhan
Journal:  EPMA J       Date:  2020-08-13       Impact factor: 6.543

3.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

4.  Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches.

Authors:  Biao Li; Xiaowei Wang; Chenguang Yang; Siqi Wen; Jiajia Li; Na Li; Ying Long; Yun Mu; Jianping Liu; Qin Liu; Xuejun Li; Dominic M Desiderio; Xianquan Zhan
Journal:  EPMA J       Date:  2021-03-03       Impact factor: 6.543

Review 5.  The crucial role of multiomic approach in cancer research and clinically relevant outcomes.

Authors:  Miaolong Lu; Xianquan Zhan
Journal:  EPMA J       Date:  2018-02-21       Impact factor: 6.543

6.  Prolactin Variants in Human Pituitaries and Pituitary Adenomas Identified With Two-Dimensional Gel Electrophoresis and Mass Spectrometry.

Authors:  Shehua Qian; Yongmei Yang; Na Li; Tingting Cheng; Xiaowei Wang; Jianping Liu; Xuejun Li; Dominic M Desiderio; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

7.  Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics.

Authors:  Na Li; Xianquan Zhan
Journal:  EPMA J       Date:  2019-06-08       Impact factor: 6.543

8.  Quantitative analysis of the human ovarian carcinoma mitochondrial phosphoproteome.

Authors:  Na Li; Shehua Qian; Biao Li; Xianquan Zhan
Journal:  Aging (Albany NY)       Date:  2019-08-22       Impact factor: 5.682

9.  Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.

Authors:  Na Li; Xianquan Zhan
Journal:  EPMA J       Date:  2019-07-19       Impact factor: 6.543

10.  A Proteomic View of Cellular Responses to Anticancer Quinoline-Copper Complexes.

Authors:  Bastien Dalzon; Joanna Bons; Hélène Diemer; Véronique Collin-Faure; Caroline Marie-Desvergne; Muriel Dubosson; Sarah Cianferani; Christine Carapito; Thierry Rabilloud
Journal:  Proteomes       Date:  2019-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.